vs
Martin Marietta Materials（MLM）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Martin Marietta Materials的季度营收约是Royalty Pharma plc的1.8倍（$1.1B vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 24.5%，领先10.0%），Royalty Pharma plc同比增速更快（4.8% vs -30.1%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -4.5%）
马丁·玛丽埃塔材料公司是美国大型集料及重型建筑材料供应商，业务覆盖美国26个州、加拿大及加勒比地区，主要为道路、人行道、地基等各类基建项目提供所需原材料。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
MLM vs RPRX — 直观对比
营收规模更大
MLM
是对方的1.8倍
$622.0M
营收增速更快
RPRX
高出34.9%
-30.1%
净利率更高
RPRX
高出10.0%
24.5%
两年增速更快
RPRX
近两年复合增速
-4.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $622.0M |
| 净利润 | $279.0M | $214.2M |
| 毛利率 | 35.0% | — |
| 营业利润率 | 24.6% | 62.4% |
| 净利率 | 24.5% | 34.4% |
| 营收同比 | -30.1% | 4.8% |
| 净利润同比 | -4.8% | 2.9% |
| 每股收益（稀释后） | $4.59 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MLMRPRX
| Q4 25 | $1.1B | $622.0M | ||
| Q3 25 | $1.8B | $609.3M | ||
| Q2 25 | $1.8B | $578.7M | ||
| Q1 25 | $1.4B | $568.2M | ||
| Q4 24 | $1.6B | $593.6M | ||
| Q3 24 | $1.9B | $564.7M | ||
| Q2 24 | $1.8B | $537.3M | ||
| Q1 24 | $1.3B | $568.0M |
净利润MLMRPRX
| Q4 25 | $279.0M | $214.2M | ||
| Q3 25 | $414.0M | $288.2M | ||
| Q2 25 | $328.0M | $30.2M | ||
| Q1 25 | $116.0M | $238.3M | ||
| Q4 24 | $293.0M | $208.2M | ||
| Q3 24 | $363.0M | $544.0M | ||
| Q2 24 | $294.0M | $102.0M | ||
| Q1 24 | $1.0B | $4.8M |
毛利率MLMRPRX
| Q4 25 | 35.0% | — | ||
| Q3 25 | 33.1% | — | ||
| Q2 25 | 30.0% | — | ||
| Q1 25 | 24.8% | — | ||
| Q4 24 | 30.0% | — | ||
| Q3 24 | 31.7% | — | ||
| Q2 24 | 29.3% | — | ||
| Q1 24 | 21.7% | — |
营业利润率MLMRPRX
| Q4 25 | 24.6% | 62.4% | ||
| Q3 25 | 27.4% | 70.1% | ||
| Q2 25 | 25.3% | 36.3% | ||
| Q1 25 | 14.3% | 94.0% | ||
| Q4 24 | 24.4% | 60.9% | ||
| Q3 24 | 25.9% | — | ||
| Q2 24 | 22.6% | 50.2% | ||
| Q1 24 | — | -13.0% |
净利率MLMRPRX
| Q4 25 | 24.5% | 34.4% | ||
| Q3 25 | 22.4% | 47.3% | ||
| Q2 25 | 18.1% | 5.2% | ||
| Q1 25 | 8.6% | 41.9% | ||
| Q4 24 | 18.0% | 35.1% | ||
| Q3 24 | 19.2% | 96.3% | ||
| Q2 24 | 16.7% | 19.0% | ||
| Q1 24 | 83.5% | 0.8% |
每股收益（稀释后）MLMRPRX
| Q4 25 | $4.59 | $0.49 | ||
| Q3 25 | $6.85 | $0.67 | ||
| Q2 25 | $5.43 | $0.07 | ||
| Q1 25 | $1.90 | $0.55 | ||
| Q4 24 | $4.87 | $0.46 | ||
| Q3 24 | $5.91 | $1.21 | ||
| Q2 24 | $4.76 | $0.23 | ||
| Q1 24 | $16.87 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $67.0M | $618.7M |
| 总债务越低越好 | $5.3B | $9.0B |
| 股东权益账面价值 | $10.0B | $9.7B |
| 总资产 | $18.7B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.53× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资MLMRPRX
| Q4 25 | $67.0M | $618.7M | ||
| Q3 25 | $57.0M | $938.9M | ||
| Q2 25 | $225.0M | $631.9M | ||
| Q1 25 | $101.0M | $1.1B | ||
| Q4 24 | $670.0M | $929.0M | ||
| Q3 24 | $52.0M | $950.1M | ||
| Q2 24 | $109.0M | $1.8B | ||
| Q1 24 | $2.6B | $843.0M |
总债务MLMRPRX
| Q4 25 | $5.3B | $9.0B | ||
| Q3 25 | $5.5B | $8.9B | ||
| Q2 25 | $5.4B | $8.0B | ||
| Q1 25 | $5.4B | $7.6B | ||
| Q4 24 | $5.4B | $7.6B | ||
| Q3 24 | $4.0B | $7.6B | ||
| Q2 24 | $4.3B | $7.6B | ||
| Q1 24 | $4.3B | $6.1B |
股东权益MLMRPRX
| Q4 25 | $10.0B | $9.7B | ||
| Q3 25 | $9.7B | $9.6B | ||
| Q2 25 | $9.4B | $9.5B | ||
| Q1 25 | $9.1B | $9.8B | ||
| Q4 24 | $9.5B | $10.3B | ||
| Q3 24 | $9.2B | $10.3B | ||
| Q2 24 | $8.8B | $9.8B | ||
| Q1 24 | $8.9B | $9.9B |
总资产MLMRPRX
| Q4 25 | $18.7B | $19.6B | ||
| Q3 25 | $18.7B | $19.3B | ||
| Q2 25 | $18.1B | $18.3B | ||
| Q1 25 | $17.7B | $17.6B | ||
| Q4 24 | $18.2B | $18.2B | ||
| Q3 24 | $16.5B | $18.0B | ||
| Q2 24 | $16.3B | $17.7B | ||
| Q1 24 | $16.2B | $16.1B |
负债/权益比MLMRPRX
| Q4 25 | 0.53× | 0.92× | ||
| Q3 25 | 0.57× | 0.93× | ||
| Q2 25 | 0.58× | 0.84× | ||
| Q1 25 | 0.60× | 0.78× | ||
| Q4 24 | 0.57× | 0.74× | ||
| Q3 24 | 0.44× | 0.74× | ||
| Q2 24 | 0.49× | 0.78× | ||
| Q1 24 | 0.49× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $629.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $424.0M | — |
| 自由现金流率自由现金流/营收 | 37.2% | — |
| 资本支出强度资本支出/营收 | 18.0% | — |
| 现金转化率经营现金流/净利润 | 2.25× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $978.0M | — |
8季度趋势，按日历期对齐
经营现金流MLMRPRX
| Q4 25 | $629.0M | $827.1M | ||
| Q3 25 | $551.0M | $702.6M | ||
| Q2 25 | $387.0M | $364.0M | ||
| Q1 25 | $218.0M | $596.1M | ||
| Q4 24 | $686.0M | $742.5M | ||
| Q3 24 | $600.0M | $703.6M | ||
| Q2 24 | $1.0M | $658.2M | ||
| Q1 24 | $172.0M | $664.6M |
自由现金流MLMRPRX
| Q4 25 | $424.0M | — | ||
| Q3 25 | $361.0M | — | ||
| Q2 25 | $208.0M | — | ||
| Q1 25 | $-15.0M | — | ||
| Q4 24 | $453.0M | — | ||
| Q3 24 | $317.0M | — | ||
| Q2 24 | $-138.0M | — | ||
| Q1 24 | $-28.0M | — |
自由现金流率MLMRPRX
| Q4 25 | 37.2% | — | ||
| Q3 25 | 19.6% | — | ||
| Q2 25 | 11.5% | — | ||
| Q1 25 | -1.1% | — | ||
| Q4 24 | 27.8% | — | ||
| Q3 24 | 16.8% | — | ||
| Q2 24 | -7.8% | — | ||
| Q1 24 | -2.2% | — |
资本支出强度MLMRPRX
| Q4 25 | 18.0% | — | ||
| Q3 25 | 10.3% | — | ||
| Q2 25 | 9.9% | — | ||
| Q1 25 | 17.2% | — | ||
| Q4 24 | 14.3% | — | ||
| Q3 24 | 15.0% | — | ||
| Q2 24 | 7.9% | — | ||
| Q1 24 | 16.0% | — |
现金转化率MLMRPRX
| Q4 25 | 2.25× | 3.86× | ||
| Q3 25 | 1.33× | 2.44× | ||
| Q2 25 | 1.18× | 12.06× | ||
| Q1 25 | 1.88× | 2.50× | ||
| Q4 24 | 2.34× | 3.57× | ||
| Q3 24 | 1.65× | 1.29× | ||
| Q2 24 | 0.00× | 6.45× | ||
| Q1 24 | 0.16× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MLM
| Building Materials Business East Group | $774.0M | 68% |
| Building Materials Business West Group | $233.0M | 20% |
| Services | $88.0M | 8% |
| Other | $45.0M | 4% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
